메뉴 건너뛰기
Diabetes Care
Volumn 32, Issue 7, 2009, Pages
Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA diabetes trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association: Response to Lund and Vaag
Author keywords

[No Author keywords available]
Indexed keywords

HEMOGLOBIN A1C;
EID: 67650069750     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-9031     Document Type: Letter
Times cited : (78)
References (3)
  • 1
    • 67650080865 scopus 로고    scopus 로고
    • Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association (Letter)
    • DOI: 10.2337/dc09-9030
    • Lund SS, Vaag A. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association (Letter). Diabetes Care 2009;32:e90. DOI: 10.2337/dc09-9030
    • (2009) Diabetes Care , vol.32
    • Lund, S.S.1    Vaag, A.2
  • 2
    • 63149103614 scopus 로고    scopus 로고
    • Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
    • Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EAM, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care 2009;32:187-192.
    • (2009) Diabetes Care , vol.32 , pp. 187-192
    • Skyler, J.S.1    Bergenstal, R.2    Bonow, R.O.3    Buse, J.4    Deedwania, P.5    Gale, E.A.M.6    Howard, B.V.7    Kirkman, M.S.8    Kosiborod, M.9    Reaven, P.10    Sherwin, R.S.11
  • 3
    • 57349160286 scopus 로고    scopus 로고
    • the American Diabetes Association, the European Association for the Study of Diabetes. Medical management of hyperglycaemia in type 2 diabetes mellitus: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
    • Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B, the American Diabetes Association, the European Association for the Study of Diabetes. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2009;52:17-30
    • (2009) Diabetologia , vol.52 , pp. 17-30
    • Nathan, D.M.1    Buse, J.B.2    Davidson, M.B.3    Ferrannini, E.4    Holman, R.R.5    Sherwin, R.6    Zinman, B.7

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.